Skip to main content
×
Home
    • Aa
    • Aa

Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: A systematic review and economic evaluation

  • Jackie Bryant (a1), Hakan Brodin (a1), Emma Loveman (a1) and Andrew Clegg (a1)
Abstract

Objectives: The clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators (ICD) for arrhythmias was assessed.

Methods: A systematic review of the literature of systematic reviews and randomized controlled trials that reported mortality outcomes associated with implantable cardioverter defibrillators compared with antiarrhythmic drug therapy in people at risk of sudden cardiac death due to arrhythmias was undertaken. Economic evaluations were also sought. Inclusion criteria, data extraction, and quality assessment were undertaken by standard methodology. A decision analytic model was constructed using best available evidence to determine cost-effectiveness in a UK setting.

Results: Eight randomized controlled trials, two systematic reviews, and a meta-analysis met the inclusion criteria and were of variable quality. Evidence suggests that ICDs reduce mortality in both secondary and primary prevention, although the magnitude of benefit depends on baseline risk for sudden cardiac death. Incremental cost per quality-adjusted life year ranged from £52,000 ($98,000) to over £200,000 ($379,000), depending on mortality risk and assumptions made.

Conclusions: Evidence suggests that ICDs reduce total mortality but may be cost-effective only in some subgroups of patients at high risk of ventricular arrhythmias. Further research is needed on risk stratification of patients in whom ICDs are most likely to be clinically and cost-effective.

Copyright
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

BanschD, AntzM, BoczorS, et al. 2002Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation.105: 14531458.

BardyGH, LeeKL, MarkDB, et al. 2005Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med.352: 225237.

BiggerJTJr. 1997Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med.337: 15691575.

BristowMR, SaxonLA, BoehmerJ. 2004Cardiac resynchronisation therapy with or without an implantable cardioverter defibrillator in advanced chronic heart failure. N Engl J Med.350: 21402150.

BryantJ, BrodinH, LovemanE, et al. 2005The clinical effectiveness and cost effectiveness of implantable cardioverter defibrillators: Arrhythmias. Health Technol Assess.9: 36.

BuxtonAE, LeeKL, FisherJD. 1999A randomized study of the prevention of sudden cardiac death in patients with coronary artery disease. N Engl J Med.341: 18821890.

ConnollySJ, GentM, RobertsRS. 2000Canadian Implantable Defibrillator Study (CIDS) A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation.101: 12971302.

ConnollySJ, HallstromAP, CappatoR, et al. 2000Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator Study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J.21: 20712078.

de Vreede-SwagemakersJJ, GorgelsAP, Dubois-ArbouwWI, et al. 1997Out-of-hospital cardiac arrest in the 1990's: A population-based study in the Maastrict area on incidence, characteristics and survival. J Am Coll Cardiol.30: 15001505.

DrummondMF, JeffersonTO. 1996Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ.313: 275283.

EzekowitzJA, ArmstrongPW, McAlisterFA. 2003Implantable cardioverter defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trials. Ann Intern Med.138: 445452.

HlatkyM. 2004Evidence-based use of cardiac procedures and devices. N Engl J Med.350: 21262128.

IrvineJ, DorianP, BakerB, et al. 2002Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J.144: 282289.

JadadAR, MooreA, CarrollD. 1996Assessing the quality of reports of randomised clinical trials: Is blinding necessary? Control Clin Trials.17: 112.

KadishA, DyerA, DaubertJP, et al. 2004Prophylactic defibrillator implantation with nonischemic dilated cardiomyopathy. N Engl J Med.350: 21512158.

KuckKH, CappatoR, SiebelsJ, et al. 2000Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation.102: 748754.

KupersmithJ, HoganA, GuerreroP, et al. 1995Evaluating and improving the cost-effectiveness of the implantable cardioverter-defibrillator. Am Heart J.130(Pt 1): 507515.

KuppermannM, LuceBR, McGovernB. 1990An analysis of the cost effectiveness of the implantable defibrillator. Circulation.81: 91100.

LarsenG, HallstromA, McAnultyJ, et al. 2002Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: Results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy. Circulation.105: 20492057.

LarsenGC, ManolisAS, SonnenbergFA, et al. 1992Cost-effectiveness of the implantable cardioverter-defibrillator: Effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol.19: 13231334.

LeeDS, GreenLD, LiuPP, et al. 2003Effectiveness of implantable defibrillators for preventing arrhythmic events and death: A meta-analysis. J Am Coll Cardiol.41: 15731582.

MossAJ, FadlY, ZarebaW, et al. 2001Defibrillator Implantation Trial Research Group. Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. Am J Cardiol.88: 516520.

MossAJ, HallWJ, CannomDS, et al. 1996Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med.335: 19331940.

MossAJ, ZarebaW, HallWJ, et al. 2002Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med.346: 877883.

NamerowPB, FirthBR, HeywoodGM, et al. 1999Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: Findings from the CABG Patch Trial. Pacing Clin Electrophysiol.22: 13051313.

O'BrienBJ, BuxtonMJ, RuskinJN. 1992Cost effectiveness of the implantable cardioverter-defibrillator: A preliminary analysis. Br Heart J.68: 241245.

O'BrienBJ, ConnollySJ, GoereeR, et al. 2001Cost-effectiveness of the implantable cardioverter-defibrillator: Results from the Canadian Implantable Defibrillator Study (CIDS). Circulation.103: 14161421.

O'BrienBJ, HeylandD, RichardsonWS, et al. 1997Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA.277: 18021806.

OwensDK, SandersGD, HarrisRA, et al. 1997Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med.126: 112.

OwensDK, SandersGD, HeidenreichPA, et al. 2002Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. Am Heart J.144: 440448.

SandersGD, HlatkyMA, EveryNR, et al. 2001Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. Ann Intern Med.135: 870883.

SchronEB, ExnerDV, YaoQ, et al. 2002Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation.105: 589594.

SeidlK, SengesJ. 2003Worldwide utilisation of implantable cardioverter defibrillators now and in the future. Card Electrophysiol Rev.7: 513.

WeverEF, HauerRN, SchwetzKM. 1996Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. Circulation.93: 489496.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 1
Total number of PDF views: 11 *
Loading metrics...

Abstract views

Total abstract views: 96 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 30th March 2017. This data will be updated every 24 hours.